Log in

OTCMKTS:ORINYORION OYJ/ADR Stock Price, Forecast & News

0.00 (0.00 %)
(As of 03/25/2020)
Today's Range
Now: $18.65
50-Day Range
MA: $20.18
52-Week Range
Now: $18.65
Volume272 shs
Average Volume14 shs
Market Capitalization$5.27 billion
P/E Ratio23.61
Dividend YieldN/A
Orion Oyj engages in the development and manufacture of pharmaceuticals, active pharmaceutical ingredients (APIs), and diagnostic tests worldwide. The company operates in two segments, Pharmaceuticals and Diagnostics. The Pharmaceuticals segment develops, manufactures, and markets pharmaceuticals and APIs. This segment provides proprietary drugs in the areas of central nervous system, oncology and critical care, and pulmonary care; generic prescription drugs, as well as self-care products, such as non-prescription medicines, basic ointments, and vitamins; proprietary and generic veterinary drugs; and APIs for generic and proprietary drugs, as well as offers contract manufacturing services for APIs. This segment also markets and sells veterinary drugs manufactured by other international companies. The Diagnostics segment develops, manufactures, and markets in vitro diagnostic test systems and tests for diagnosing diseases and monitoring treatment efficacy. Orion Oyj has a strategic alliance with Novan, Inc. to manufacture topical nitric oxide-releasing product candidates; and research collaboration with Fifth Corner Inc. to seek solutions to improve the quality of life of prostate cancer patients. The company was founded in 1917 and is headquartered in Espoo, Finland.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.42 out of 5 stars

Industry, Sector and Symbol

Industry Private households
Previous SymbolNASDAQ:ORINY
Phone358 10 4261



Sales & Book Value

Annual Sales$1.18 billion
Cash Flow$1.08 per share
Book Value$3.10 per share


Net Income$224.45 million


Market Cap$5.27 billion
Next Earnings Date4/23/2020 (Estimated)
OptionableNot Optionable

Receive ORINY News and Ratings via Email

Sign-up to receive the latest news and ratings for ORINY and its competitors with MarketBeat's FREE daily newsletter.

ORION OYJ/ADR (OTCMKTS:ORINY) Frequently Asked Questions

How has ORION OYJ/ADR's stock been impacted by COVID-19 (Coronavirus)?

ORION OYJ/ADR's stock was trading at $20.78 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ORINY shares have decreased by 10.3% and is now trading at $18.65. View which stocks have been most impacted by Coronavirus.

When is ORION OYJ/ADR's next earnings date?

ORION OYJ/ADR is scheduled to release its next quarterly earnings announcement on Thursday, April 23rd 2020. View our earnings forecast for ORION OYJ/ADR.

How were ORION OYJ/ADR's earnings last quarter?

ORION OYJ/ADR (OTCMKTS:ORINY) issued its quarterly earnings data on Wednesday, February, 5th. The company reported $0.18 earnings per share (EPS) for the quarter. The company had revenue of $303.95 million for the quarter. ORION OYJ/ADR had a return on equity of 29.17% and a net margin of 19.06%. View ORION OYJ/ADR's earnings history.

Has ORION OYJ/ADR been receiving favorable news coverage?

News coverage about ORINY stock has trended very negative this week, InfoTrie reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. ORION OYJ/ADR earned a coverage optimism score of -3.3 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news aboutORION OYJ/ADR.

Who are some of ORION OYJ/ADR's key competitors?

What other stocks do shareholders of ORION OYJ/ADR own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ORION OYJ/ADR investors own include Primo Water (PRMW), KeyCorp (KEY), RLI (RLI), Axon Enterprise (AAXN), Adaptimmune Therapeutics (ADAP), BioMarin Pharmaceutical (BMRN), First Busey (BUSE), Bazaarvoice (BV), Domo (DOMO) and Eagle Pharmaceuticals (EGRX).

Who are ORION OYJ/ADR's key executives?

ORION OYJ/ADR's management team includes the following people:
  • Mr. Timo Lappalainen, CEO, Pres & Chairman of the Exec. Management Board (Age 57)
  • Mr. Jari Karlson M.Sc. (Econ.), CFO, Sr. VP of Animal Health & Member of the Exec. Management Board (Age 58)
  • Mr. Olli Huotari, Sr. VP of Corp. Functions, Gen. Counsel, Sec. & Member of Exec. Management Board (Age 53)
  • Mr. Markku Huhta-Koivisto, Sr. VP of Growth Projects & Member of Exec. Management Board (Age 63)
  • Ms. Satu Ahomäki, Sr. VP of Commercial Operations and Member of the Exec. Management Board (Age 53)

What is ORION OYJ/ADR's stock symbol?

ORION OYJ/ADR trades on the OTCMKTS under the ticker symbol "ORINY."

How do I buy shares of ORION OYJ/ADR?

Shares of ORINY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ORION OYJ/ADR's stock price today?

One share of ORINY stock can currently be purchased for approximately $18.65.

How big of a company is ORION OYJ/ADR?

ORION OYJ/ADR has a market capitalization of $5.27 billion and generates $1.18 billion in revenue each year. The company earns $224.45 million in net income (profit) each year or $0.80 on an earnings per share basis. ORION OYJ/ADR employs 3,179 workers across the globe. View additional information about ORION OYJ/ADR.

What is ORION OYJ/ADR's official website?

The official website for ORION OYJ/ADR is http://www.orion.fi/.

How can I contact ORION OYJ/ADR?

ORION OYJ/ADR's mailing address is Orionintie 1A, Espoo H9, 02200. The company can be reached via phone at 358 10 4261 or via email at [email protected]

This page was last updated on 4/9/2020 by MarketBeat.com Staff

Featured Article: Cost of Goods Sold (COGS)

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel